Informatie:
Fout:
ID
34330
Beschrijving
Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4; ODM derived from: https://clinicaltrials.gov/show/NCT01884402
Link
https://clinicaltrials.gov/show/NCT01884402
Trefwoorden
Versies (1)
- 16-01-19 16-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
16 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hepatitis C, Chronic NCT01884402
Eligibility Hepatitis C, Chronic NCT01884402
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C, Chronic NCT01884402
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
patients with > 18 years old.
boolean
ID.2
Item
patients diagnosed with chronic hepatitis c in the presence of hcv rna in plasma that meet criteria for initiating antiviral therapy in routine clinical practice conditions.
boolean
ID.3
Item
patients genotype 1 and 4.
boolean
ID.4
Item
patients with the results of all the factors evaluable at the time of inclusion.
boolean
ID.5
Item
patients who have accepted their participation in the study through informed consent.
boolean
ID.6
Item
patients previously treated with interferon (ifn) and ribavirin (rbv).
boolean
ID.7
Item
patients with genotype 2, 3, 5 and 6.
boolean
ID.8
Item
patients with co-infection with hepatitis b.
boolean
ID.9
Item
patients with other liver diseases.
boolean
ID.10
Item
patients with any contraindications to the drugs used in the treatment of hepatitis
boolean